Literature DB >> 11062722

Expression and activity of DNA-dependent protein kinase in normal human leukocytes.

A Eriksson1, R Lewensohn, A Nilsson.   

Abstract

BACKGROUND: DNA-PK is a serine/threonine protein kinase that has been shown to play an important role in V(D)J recombination, Ig switching and DNA double strand break (DSB) repair. We have investigated DNA-PK in whole cell extracts from B and T lymphocytes, monocytes and granulocytes and the effects of phorbolmyristate acetate (PMA) and Concanavalin A (Con A) on DNA-PK in B and T lymphocytes.
MATERIALS AND METHODS: Lymphocytes were separated from human peripheral blood using the E-rosette technique and DNA-PK was analysed using Western blot, DNA-PK kinase activity assay and flow cytometry.
RESULTS: The levels of DNA-PK activity and content varied among the leukocytes. PMA and Con A stimulation consistently increased both DNA-PK activity and content in B lymphocytes as cells entered the S phase. Up-regulation could normally not be seen in T lymphocytes, although cells entered the S phase following PMA and Con A stimulation.
CONCLUSION: Mitogenic stimulation up-regulates DNA-PK activity and protein expression in B lymphocytes. T lymphocytes show interindividual differences in DNA-PK. Regulation of DNA-PK is not strictly cell cycle dependent for all cell types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062722

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Targeting abnormal DNA double strand break repair in cancer.

Authors:  Feyruz V Rassool; Alan E Tomkinson
Journal:  Cell Mol Life Sci       Date:  2010-08-10       Impact factor: 9.261

2.  The profiles of gamma-H2AX along with ATM/DNA-PKcs activation in the lymphocytes and granulocytes of rat and human blood exposed to gamma rays.

Authors:  Jing Wang; Lina Yin; Junxiang Zhang; Yaping Zhang; Xuxia Zhang; Defang Ding; Yun Gao; Qiang Li; Honghong Chen
Journal:  Radiat Environ Biophys       Date:  2016-06-03       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.